TABLE 2.

Biodistribution of ¹¹¹In-1 in Healthy CF-1 Mice at 1-hr Post-Injection in the presence and absence of 100 μg BBN (n = 3).^a

Organ/Tissues	Blocked	Control
Bladder	1.96 ± 1.39	0.99 ± 0.69
Heart	0.13 ± 0.02	0.09 ± 0.04
Lung	0.35 ± 0.05	1.37 ± 0.08
Liver	0.24 ± 0.01	0.26 ± 0.07
Kidneys	1.44 ± 0.26	1.54 ± 0.16
Spleen	0.11 ± 0.04	0.17 ± 0.03
Stomach	0.11 ± 0.03	0.38 ± 0.07
S. Intestine	0.69 ± 0.11	0.90 ± 0.28
L. Intestine	0.13 ± 0.03	0.44 ± 0.31
Muscle	0.06 ± 0.01	0.04 ± 0.01
Bone	0.09 ± 0.03	0.07 ± 0.01
Brain	0.02 ± 0.00	0.01 ± 0.00
Pancreas	0.20 ± 0.01	2.04 ± 0.17
Blood	0.24 ± 0.02	0.16 ± 0.09
Carcass	0.20 ± 0.02	0.16 ± 0.01
Excretion (% ID ± SD)	91.25 ± 0.44	90.97 ± 1.08

^aAll data, except excretion, are presented as an average %ID/g ± SD.